Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan

Nakano Y, Kurano M, Morita Y, Shimura T, Yokoyama R, Qian C, Xia F, He F, Kishi Y, Okada J, Yoshikawa N, Nagura Y, Okazaki H, Moriya K, Seto Y, Kodama T, Yatomi Y.Sci Rep. 2021 02 02;11(1):2776. doi: 10.1038/s41598-021-82428-5